{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:40:33Z","timestamp":1771166433530,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With China experiencing unprecedented economic development and social change over the past three decades, Chinese policy makers and health care professionals have come to view mental health as an important outcome to monitor. Our study conducted an epidemiological study of psychosis in Guangdong province, with 20 million real-world follow-up records in the last decade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data was collected from Guangdong mental health information platform from 2010 to 2019, which had standardized disease registration and follow-up management for nearly 600,000 patients with six categories of mental diseases and 400,000 patients with schizophrenia. We conducted clinical staging for the disease course of the patients and divided the data with various factors into different stages of disease. Quantitative analysis was utilized to investigate the high relevant indicators to the disease. The results were projected on geography map for regional distribution analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The majority cases of mental disease incidence were between the age of 15 and 29, while the peak age for both male and female was between 20 to 24\u2009years old. The disease course with the largest number of patients\u2019 cases was between 5 to 10\u2009years. The therapeutic effect of patients gradually decreased with the development of disease course, while the risk increased with the disease course. The analysis of influencing factors showed that poor economic conditions incurred higher risk scores, and good medication adherence was effective in improving treatment outcomes. In addition, receiving good education contributed to the reduction of the risk of schizophrenia and the improvement of the efficiency of early treatment. Through the analysis of regional distribution of schizophrenia disease, developed economic conditions and favorable resource conditions could promote the reduction of disease risk, while in economically backward regions, it often accompanied with lower therapeutic effect and higher disease risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Certain demographic factors had a relatively prominent impact on the therapeutic effect and risk of schizophrenia, such as high-quality medication adherence. Therapeutic effect and risk were highly correlated. Backward economic conditions often associated with poor efficacy and higher risk assessment, and the developed economy and better medical resource are beneficial for the treatment of psychotic.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-020-1125-0","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:08:50Z","timestamp":1594282130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The psychosis analysis in real-world on a cohort of large-scale patients with schizophrenia"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenyan","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haicheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.schres.2015.07.007","volume":"168","author":"D Naber","year":"2015","unstructured":"Naber D, Hansen K, et al. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia. Schizophr Res. 2015;168:498\u2013504.","journal-title":"Schizophr Res"},{"issue":"2","key":"1125_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010;196(2):116\u201321.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"1125_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/YCO.0b013e32816ebc8c","volume":"20","author":"RC Kessler","year":"2007","unstructured":"Kessler RC, et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20(4):359\u201364.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"1125_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1017\/S2045796014000687","volume":"24","author":"FJ Charlson","year":"2015","unstructured":"Charlson FJ, Baxter AJ, et al. Excess mortality from mental, neurological and substance use disorders in the global burden of disease study 2010. Epidemiol Psychiatric Sci. 2015;24(2):121\u201340.","journal-title":"Epidemiol Psychiatric Sci"},{"issue":"10","key":"1125_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","volume":"64","author":"S Saha","year":"2007","unstructured":"Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123\u201331.","journal-title":"Arch Gen Psychiatry"},{"key":"1125_CR6","unstructured":"Janoutov\u00e1 J, Jan\u00e1\u010dkov\u00e1 P. et al, Epidemiology and risk factors of schizophrenia. 2016;37(1):1\u20138."},{"key":"1125_CR7","doi-asserted-by":"crossref","unstructured":"McGrath JJ. The Surprisingly Rich Contours of Schizophrenia Epidemiology. 2007;64:14\u20136.","DOI":"10.1001\/archpsyc.64.1.14"},{"key":"1125_CR8","volume-title":"Epidemiology: principles and methods","author":"B MacMahon","year":"1970","unstructured":"MacMahon B, Pugh TF. Epidemiology: principles and methods. Boston: Little, Brown, and Company; 1970."},{"issue":"2","key":"1125_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamapsychiatry.2017.4184","volume":"75","author":"JJ McGrath","year":"2018","unstructured":"McGrath JJ, Mortensen PB, Whiteford HA. Pragmatic psychiatric epidemiology-if you Can\u2019t count it, It Won\u2019t Count. JAMA Psychiatry. 2018;75(2):111\u20132.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"1125_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0020764017692840","volume":"63","author":"MS Ran","year":"2017","unstructured":"Ran MS, Yang LH, et al. The family economic status and outcome of people with schizophrenia in Xinjin, Chengdu, China: 14-year follow-up study. Int J Soc Psychiatry. 2017;63(3):203\u201311.","journal-title":"Int J Soc Psychiatry"},{"issue":"5","key":"1125_CR11","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/S2468-2667(19)30056-8","volume":"4","author":"HE Jongsma","year":"2019","unstructured":"Jongsma HE, Turner G, Kirkbride JB, Jones PB. International incidence of psychotic disorders, 2002\u201317: a systematic review and meta-analysis. Lancet Public Health. 2019;4(5):e229\u201344.","journal-title":"Lancet Public Health"},{"issue":"6","key":"1125_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","volume":"60","author":"A Aleman","year":"2003","unstructured":"Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60(6):565\u201371.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1125_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1176\/appi.ajp.2016.16010103","volume":"174","author":"JB Kirkbride","year":"2017","unstructured":"Kirkbride JB, Hameed Y, et al. The epidemiology of first-episode psychosis in early intervention in psychosis services: findings from the social epidemiology of psychoses in East Anglia [SEPEA] study. Am J Psychiatr. 2017;174(2):143\u201353.","journal-title":"Am J Psychiatr"},{"issue":"1","key":"1125_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamapsychiatry.2017.3582","volume":"75","author":"L Richardson","year":"2018","unstructured":"Richardson L, Hameed Y, et al. Association of Environment with the risk of developing psychotic disorders in rural populations findings from the social epidemiology of psychoses in East Anglia study. JAMA Psychiatry. 2018;75(1):75\u201383.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"1125_CR15","first-page":"S7","volume":"190","author":"JJ McGrath","year":"2009","unstructured":"McGrath JJ, Susser ES. New directions in the epidemiology of schizophrenia. Med J Aust. 2009;190(4):S7\u20139.","journal-title":"Med J Aust"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/CEOR.S44325","volume":"5","author":"W Montgomery","year":"2013","unstructured":"Montgomery W, Liu L, et al. The personal, societal, and economic burden of schizophrenia in the People\u2019s republic of China: implications for antipsychotic therapy. Clinicoecon Outcomes Res. 2013;5:407\u201318.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"1125_CR17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","volume":"44","author":"FJ Charlson","year":"2018","unstructured":"Charlson FJ, Ferrari AJ, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44(6):1195\u2013203.","journal-title":"Schizophr Bull"},{"issue":"1","key":"1125_CR18","doi-asserted-by":"publisher","first-page":"010410","DOI":"10.7189\/jogh.05.010412","volume":"5","author":"KY Chan","year":"2015","unstructured":"Chan KY, Zhao FF, et al. Prevalence of schizophrenia in China between 1990 and 2010. J Glob Health. 2015;5(1):010410.","journal-title":"J Glob Health"},{"key":"1125_CR19","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1186\/s12940-016-0104-5","volume":"15","author":"XH Li","year":"2016","unstructured":"Li XH, Song JC, et al. Urbanization and health in China, thinking at the national, local and individual levels. Environ Health. 2016;15:S32.","journal-title":"Environ Health"},{"issue":"11","key":"1125_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00127-016-1270-z","volume":"51","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liu ZR, et al. The China mental health survey (CMHS): I. background, aims and measures. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1559\u201369.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"11","key":"1125_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00127-016-1269-5","volume":"51","author":"ZR Liu","year":"2016","unstructured":"Liu ZR, Huang YQ, et al. The China mental health survey: II. Design and field procedures. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1547\u201357.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"1125_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/acps.12296","volume":"130","author":"J Long","year":"2014","unstructured":"Long J, Huang G, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244\u201356.","journal-title":"Acta Psychiatr Scand"},{"issue":"9680","key":"1125_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(09)60660-7","volume":"373","author":"MR Phillips","year":"2009","unstructured":"Phillips MR, Zhang JX, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001\u201305: an epidemiological survey. Lancet. 2009;373(9680):13\u20139.","journal-title":"Lancet"},{"key":"1125_CR24","doi-asserted-by":"crossref","unstructured":"Shen YC, Zhang MY, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med. 2006:257\u201367.","DOI":"10.1017\/S0033291705006367"},{"issue":"1","key":"1125_CR25","first-page":"3","volume":"9","author":"TW Hu","year":"2006","unstructured":"Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990\u20132003. J Ment Health Policy Econ. 2006;9(1):3\u201313.","journal-title":"J Ment Health Policy Econ"},{"issue":"5","key":"1125_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly C, Castle D, et al. Royal Australian and new Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410\u201372.","journal-title":"Aust N Z J Psychiatry"},{"key":"1125_CR27","doi-asserted-by":"crossref","unstructured":"Ochoa S, Usall J, Cobo J, et al. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treat. 2012;576369.","DOI":"10.1155\/2012\/916198"},{"issue":"4","key":"1125_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K, Medic G, et al. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200\u201318.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"12","key":"1125_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","volume":"63","author":"DO Perkins","year":"2002","unstructured":"Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry. 2002;63(12):1121\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1125_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1752-4458-7-26","volume":"7","author":"J Zhai","year":"2013","unstructured":"Zhai J, Guo XF, et al. An investigation of economic costs of schizophrenia in two areas of China. Int J Ment Heal Syst. 2013;7(1):26.","journal-title":"Int J Ment Heal Syst"},{"issue":"2","key":"1125_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00127-004-0715-y","volume":"39","author":"M Byrne","year":"2004","unstructured":"Byrne M, Agerbo E, et al. Parental socio-economic status and risk of first admission with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2004;39(2):87\u201396.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"1125_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.psychres.2012.09.059","volume":"208","author":"K Scior","year":"2013","unstructured":"Scior K, Potts HW, et al. Awareness of schizophrenia and intellectual disability and stigma across ethnic groups in the UK. Psychiatry Res. 2013;208(2):125\u201330.","journal-title":"Psychiatry Res"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","volume":"65","author":"J Davis","year":"2016","unstructured":"Davis J, Eyre H, et al. A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev. 2016;65:185\u201394.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1125_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"YP Huang","year":"2019","unstructured":"Huang YP, Wang Y, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211\u201324.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"1125_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/j.2051-5545.2011.tb00059.x","volume":"10","author":"J Liu","year":"2011","unstructured":"Liu J, Ma H, et al. Mental health system in China: history, recent service reform and future challenges. World Psychiatry. 2011;10(3):210\u20136.","journal-title":"World Psychiatry"},{"issue":"4","key":"1125_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chieco.2009.05.011","volume":"20","author":"KY Dong","year":"2009","unstructured":"Dong KY. Medical insurance system evolution in China. China Econ Rev. 2009;20(4):591\u20137.","journal-title":"China Econ Rev"},{"issue":"8","key":"1125_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/PSY.0b013e3181baa65e","volume":"71","author":"S Lee","year":"2009","unstructured":"Lee S, Guo WJ, et al. Impaired role functioning and treatment rates for mental disorders and chronic physical disorders in metropolitan China. Psychosom Med. 2009;71(8):886\u201393.","journal-title":"Psychosom Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-1125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-020-1125-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-1125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:21:21Z","timestamp":1625786481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-020-1125-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":37,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s12911-020-1125-0","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"9 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}